The estimated Net Worth of Robert K. Rockwood is at least $9.59 Million dollars as of 8 April 2014. Robert Rockwood owns over 518 units of Cencora stock worth over $9,417,619 and over the last 14 years Robert sold COR stock worth over $167,811.
Robert has made over 7 trades of the Cencora stock since 2013, according to the Form 4 filled with the SEC. Most recently Robert sold 518 units of COR stock worth $16,555 on 8 April 2014.
The largest trade Robert's ever made was selling 1,485 units of Cencora stock on 30 September 2013 worth over $50,846. On average, Robert trades about 500 units every 40 days since 2010. As of 8 April 2014 Robert still owns at least 39,868 units of Cencora stock.
You can see the complete history of Robert Rockwood stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is 1050 17TH STREET, SUITE 800, , DENVER, CO, 80265.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... und Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: